Detalles de la búsqueda
1.
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Ophthalmology;
126(6): 792-800, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703441
2.
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Ophthalmology;
121(2): 475-83, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24289915
3.
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.
J Ocul Pharmacol Ther;
39(9): 600-610, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677000
4.
Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
Allergy Asthma Proc;
33(3): 265-74, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22991696
5.
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.
Clin Ther;
44(9): 1178-1186, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965109
6.
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease.
Cornea;
41(10): 1207-1216, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36107843
7.
Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment.
Ocul Surf;
18(2): 249-257, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31542368
8.
Management of Ocular Allergy Itch With an Antihistamine-Releasing Contact Lens.
Cornea;
38(6): 713-717, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30908338
9.
Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects.
Clin Ophthalmol;
13: 403-413, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30858690
10.
Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.
Clin Exp Optom;
102(2): 131-139, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30525235
11.
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease.
Clin Ophthalmol;
13: 261-275, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30858682
12.
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials.
Ocul Surf;
17(1): 142-150, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30472141
13.
Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
Clin Ther;
30(11): 2005-14, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19108788
14.
Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study.
Clin Ther;
30(7): 1264-71, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691985
15.
Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis.
Clin Ther;
30(7): 1272-82, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691986
16.
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model.
Clin Ophthalmol;
12: 2617-2628, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587908
17.
Evaluation of Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution, 0.025% for Treatment of Ocular Redness.
Curr Eye Res;
43(1): 43-51, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29120262
18.
An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis.
Clin Ther;
29(4): 611-6, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17617284
19.
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis.
Clin Ophthalmol;
11: 1089-1097, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652694
20.
Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye.
Clin Ophthalmol;
11: 1883-1889, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089744